State Street Corp Gossamer Bio, Inc. Transaction History

State Street Corp

$2.21 Trillion
Q1 2024

A detailed history of State Street Corp transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, State Street Corp holds 689,251 shares of GOSS stock, worth $661,680. This represents 0.0% of its overall portfolio holdings.

Number of Shares

689,251

Previous 713,551 3.41%

Holding current value

$661,680

Previous $649,000 25.27%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.8 - $1.51 $19,440 - $36,693	-24,300 Reduced 3.41%	689,251 $813,000
Q4 2023 Feb 14, 2024	BUY	$0.48 - $1.08 $184,032 - $414,072	383,400 Added 116.13%	713,551 $649,000
Q3 2023 Nov 14, 2023	SELL	$0.78 - $1.82 $11,388 - $26,572	-14,600 Reduced 4.23%	330,151 $274,000
Q2 2023 Aug 14, 2023	SELL	$0.98 - $1.53 $959,171 - $1.5 Million	-978,746 Reduced 73.95%	344,751 $413,000
Q1 2023 May 15, 2023	SELL	$0.96 - $2.92 $25.5 Million - $77.4 Million	-26,520,488 Reduced 95.25%	1,323,497 $1.67 Million

Q4 2022 Feb 14, 2023	BUY	$1.74 - $12.87 $41.9 Million - $310 Million	24,066,082 Added 637.02%	27,843,985 $60.4 Million
Q3 2022 Nov 15, 2022	SELL	$7.21 - $14.88 $701,468 - $1.45 Million	-97,291 Reduced 2.51%	3,777,903 $45.3 Million
Q2 2022 Aug 15, 2022	BUY	$5.97 - $9.97 $3.39 Million - $5.66 Million	567,264 Added 17.15%	3,875,194 $32.4 Million
Q1 2022 May 16, 2022	BUY	$8.44 - $12.49 $133,681 - $197,829	15,839 Added 0.48%	3,307,930 $28.7 Million
Q4 2021 Feb 14, 2022	BUY	$10.12 - $14.07 $6.37 Million - $8.85 Million	629,325 Added 23.63%	3,292,091 $37.2 Million
Q3 2021 Nov 15, 2021	SELL	$7.25 - $13.23 $4.82 Million - $8.8 Million	-664,950 Reduced 19.98%	2,662,766 $33.5 Million
Q2 2021 Aug 16, 2021	SELL	$8.0 - $9.75 $4.3 Million - $5.25 Million	-537,965 Reduced 13.92%	3,327,716 $27 Million
Q1 2021 May 17, 2021	BUY	$8.63 - $10.94 $9.79 Million - $12.4 Million	1,134,827 Added 41.56%	3,865,681 $35.8 Million
Q4 2020 Feb 16, 2021	BUY	$8.3 - $13.59 $4.78 Million - $7.83 Million	575,865 Added 26.72%	2,730,854 $26.4 Million
Q3 2020 Nov 10, 2020	BUY	$11.3 - $14.75 $2.87 Million - $3.75 Million	254,417 Added 13.39%	2,154,989 $26.7 Million
Q2 2020 Aug 14, 2020	BUY	$9.52 - $15.98 $2.3 Million - $3.86 Million	241,674 Added 14.57%	1,900,572 $24.7 Million
Q1 2020 May 11, 2020	BUY	$8.0 - $15.48 $13.3 Million - $25.7 Million	1,658,898 New	1,658,898 $16.8 Million

Others Institutions Holding GOSS

# of Institutions

114

Shares Held

190M

Call Options Held

405K

Put Options Held

490K

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $90.2M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Gossamer Bio, Inc. Transaction History